171 related articles for article (PubMed ID: 6700611)
1. An evaluation of the L5178Y TK+/- mouse lymphoma forward mutation assay using 42 chemicals.
Oberly TJ; Bewsey BJ; Probst GS
Mutat Res; 1984 Feb; 125(2):291-306. PubMed ID: 6700611
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the mouse lymphoma tk assay (microwell method) as an alternative to the in vitro chromosomal aberration test.
Honma M; Hayashi M; Shimada H; Tanaka N; Wakuri S; Awogi T; Yamamoto KI; Kodani N; Nishi Y; Nakadate M; Sofuni T
Mutagenesis; 1999 Jan; 14(1):5-22. PubMed ID: 10474816
[TBL] [Abstract][Full Text] [Related]
3. Point mutations at the thymidine kinase locus in L5178Y mouse lymphoma cells. II. Test validation and interpretation.
Amacher DE; Paillet SC; Turner GN; Ray VA; Salsburg DS
Mutat Res; 1980 Aug; 72(3):447-74. PubMed ID: 7453708
[TBL] [Abstract][Full Text] [Related]
4. Procarbazine is a potent mutagen at the heterozygous thymidine kinase (tk +/-) locus of mouse lymphoma assay.
Clive D; Turner N; Krehl R
Mutagenesis; 1988 Mar; 3(2):83-7. PubMed ID: 3288842
[TBL] [Abstract][Full Text] [Related]
5. Chemical mutagenesis at the thymidine kinase locus in L5178Y mouse lymphoma cells: results for 31 coded compounds in the National Toxicology Program.
Myhr BC; Caspary WJ
Environ Mol Mutagen; 1991; 18(1):51-83. PubMed ID: 1864269
[TBL] [Abstract][Full Text] [Related]
6. The L5178Y/tk+/- mouse lymphoma specific gene and chromosomal mutation assay a phase III report of the U.S. Environmental Protection Agency Gene-Tox Program.
Mitchell AD; Auletta AE; Clive D; Kirby PE; Moore MM; Myhr BC
Mutat Res; 1997 Nov; 394(1-3):177-303. PubMed ID: 9434856
[TBL] [Abstract][Full Text] [Related]
7. Modeling the mouse lymphoma forward mutational assay: the Gene-Tox program database.
Grant SG; Zhang YP; Klopman G; Rosenkranz HS
Mutat Res; 2000 Feb; 465(1-2):201-29. PubMed ID: 10708987
[TBL] [Abstract][Full Text] [Related]
8. A statistical method for analysis of mouse lymphoma L5178Y cell TK locus forward mutation assay. Comparison of results among three laboratories.
Irr JD; Snee RD
Mutat Res; 1982 Oct; 97(5):371-92. PubMed ID: 7144804
[TBL] [Abstract][Full Text] [Related]
9. Specific gene mutations in L5178Y cells in culture.
Clive D; McCuen R; Spector JF; Piper C; Mavournin KH
Mutat Res; 1983 Jun; 115(2):225-51. PubMed ID: 6855786
[TBL] [Abstract][Full Text] [Related]
10. A comparison of the CHO/HGPRT+ and the L5178Y/TK+/- mutation assays using suspension treatment and soft agar cloning: results for 10 chemicals.
Oberly TJ; Michaelis KC; Rexroat MA; Bewsey BJ; Garriott ML
Cell Biol Toxicol; 1993; 9(3):243-57. PubMed ID: 8299003
[TBL] [Abstract][Full Text] [Related]
11. Responses of the L5178Y tk+/tk- mouse lymphoma cell forward mutation assay. II: 18 coded chemicals.
McGregor DB; Brown A; Cattanach P; Edwards I; McBride D; Caspary WJ
Environ Mol Mutagen; 1988; 11(1):91-118. PubMed ID: 3338442
[TBL] [Abstract][Full Text] [Related]
12. The mouse lymphoma assay.
Lloyd M; Kidd D
Methods Mol Biol; 2012; 817():35-54. PubMed ID: 22147567
[TBL] [Abstract][Full Text] [Related]
13. Mutation at the TK locus of mouse lymphoma L5178Y cells by 4CMB, 4HMB and BC.
Ross CA; McGregor DB
Mutat Res; 1982; 100(1-4):249-51. PubMed ID: 7057755
[No Abstract] [Full Text] [Related]
14. The need for long-term treatment in the mouse lymphoma assay.
Honma M; Zhang LZ; Sakamoto H; Ozaki M; Takeshita K; Momose M; Hayashi M; Sofuni T
Mutagenesis; 1999 Jan; 14(1):23-9. PubMed ID: 10474817
[TBL] [Abstract][Full Text] [Related]
15. Locus specificity of mutagenicity of 2,4-diaminotoluene in both L5178Y mouse lymphoma and AT3-2 Chinese hamster ovary cells.
Coppinger WJ; Brennan SA; Carver JH; Thompson ED
Mutat Res; 1984 Feb; 135(2):115-23. PubMed ID: 6694660
[TBL] [Abstract][Full Text] [Related]
16. Molecular dissection of mutations at the heterozygous thymidine kinase locus in mouse lymphoma cells.
Applegate ML; Moore MM; Broder CB; Burrell A; Juhn G; Kasweck KL; Lin PF; Wadhams A; Hozier JC
Proc Natl Acad Sci U S A; 1990 Jan; 87(1):51-5. PubMed ID: 1967496
[TBL] [Abstract][Full Text] [Related]
17. Metabolic activation capabilities of S9 liver fraction from 3 species in the L5178Y mouse-lymphoma assay.
Oberly TJ; Piper CE; McDonald DS
Mutat Res; 1982 Dec; 105(6):439-44. PubMed ID: 6818472
[No Abstract] [Full Text] [Related]
18. Mouse lymphoma L5178Y thymidine kinase locus assay of 50 compounds.
Wangenheim J; Bolcsfoldi G
Mutagenesis; 1988 May; 3(3):193-205. PubMed ID: 3045481
[TBL] [Abstract][Full Text] [Related]
19. The utilization of trifluorothymidine (TFT) to select for thymidine kinase-deficient (TK-/-) mutants from L5178Y/TK+/- mouse lymphoma cells.
Moore-Brown MM; Clive D; Howard BE; Batson AG; Johnson KO
Mutat Res; 1981 Oct; 85(5):363-78. PubMed ID: 6795499
[TBL] [Abstract][Full Text] [Related]
20. Can the L5178Y Tk+/- mouse lymphoma assay detect epigenetic silencing?
Cheng TF; Patton GW; Muldoon-Jacobs K
Food Chem Toxicol; 2013 Sep; 59():187-90. PubMed ID: 23778052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
